Collaborative Practice Agreement Certificate Program

This program will prepare pharmacists to enter into a written collaborative practice agreement (CPA) with a supervising physician in accordance with Florida law.

decorative

Program Details

  • Intended Audience: Pharmacists who would like to enter into a Collaborative Practice Agreement
  • Universal Activity Number: 0012-0000-24-001-B03-P
  • Certificate Program Number: 0012-24-001-CP
  • Contact Hours: 20.0 hours of ACPE continuing education for pharmacists (12.0 hours self-paced; 8-live, online)
  • Program Fees:
    • Regular Registration: $549.00
    • UF Preceptor/Career Coach: $449.00
    • UF COP Faculty: $425.00
  • UAN Release Date: 02/01/2024
  • UAN Expiration Date: 02/01/2027
  • Activity Type: Certificate
  • Program Support: No outside financial support was provided.
  • Format Type: This course includes a 12.0 hour self-paced, fully online home study, as well as an 8.0 hour live session (hosted via Zoom). Learners will select their live session date by enrolling in one of the available course sections. 
  • Time to Complete: All coursework must be completed within 60 days from the date of the live session or before date of UAN expiration, 02/01/2027, whichever comes first. This course will no longer be eligible for CE credit after 02/01/2027.

Summary

This program will provide insight into the regulatory requirements and clinical knowledge necessary to practice under a collaborative practice agreement.

A “collaborative pharmacy practice agreement” is a written agreement between a pharmacist who meets requirements pursuant to Section 465.1865, Florida Statutes, and a physician licensed under chapter 458 or chapter 459 in which a collaborating physician authorizes a pharmacist to provide specified patient care services to the collaborating physician’s patients.

Upon completion of this program the learner will be familiar with: the laws and rules applicable to the collaborative practice for the treatment of chronic health care conditions; writing and entering into a collaborative practice agreement; performance of patient assessments; ordering, performing, and interpreting clinical laboratory tests related to the collaborative pharmacy practice; and evaluating and managing diseases and health conditions in collaboration with other health care practitioners.


Chronic Conditions

Chronic health conditions for which a pharmacist certified pursuant to Section 465.1865, F.S., can provide specified patient care services to patients of a collaborating physician pursuant to a pending Collaborative Pharmacy Practice Agreement:

  1. Arthritis;
  2. Asthma;
  3. Chronic obstructive pulmonary diseases;
  4. Type 2 diabetes;
  5. Human immunodeficiency virus or acquired immune deficiency syndrome;
  6. Obesity;
  7. Any other chronic condition adopted in rule by the board in consultation with the Board of Medicine and the Board of Osteopathic Medicine:
    1. Hyperlipidemia;
    2. Hypertension;
    3. Anti-coagulation management;
    4. Nicotine Dependence;
    5. Opioid use disorder;
    6. Hepatitis C.

Program Objectives

At the completion of this activity, the participant will be able to:

  1. Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a Collaborative Practice Agreement in the State of Florida as outlined in Chapter 465 and Chapter 64B16-31.005.
  2. Develop a pharmacist Collaborative Practice Agreement including all required elements of a Collaborative Practice Agreement and communications, documentation, and other pertinent subjects.
  3. Describe the benefits and barriers to including pharmacists in interprofessional care teams while practicing under a Collaborative Practice Agreement.
  4. Perform patient assessments, order, perform, and interpret clinical and laboratory tests related to Collaborative Pharmacy Practice, and evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioners.
  5. Implement communication, documentation, and marketing strategies to secure and strengthen relationships with patients and providers.

Program Overview

Module 1: An Overview of Collaborative Practice Agreements in Florida

  • In this module we look at patient care in the ambulatory setting, components of collaborative practice agreements, and associated legal and professional practice requirements in the state of Florida.

Module 2: Treating and Managing Diseases and Health Conditions (Part 1)

  • In this module we will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:
    • Hyperlipidemia
    • Hypertension
    • Obesity
    • Anticoagulation
    • Nicotine Dependence

Module 3: Treating and Managing Diseases and Health Conditions (Part 2)

  • In this module we will discuss patient assessment and treatments for the following chronic diseases outlined in Florida law:
    • Type 2 Diabetes Mellitus
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Human Immunodeficiency Virus (HIV)
    • Arthritis
    • Substance Use Disorders and Opioid Reversal

Module 4: Establish and Implement Collaborative Agreements within the Practice

  • In this module we will discuss how to write a written collaborative practice agreement and building a business model and marketing plan for your practice. 

Requirements for Successful Course Completion

In order to earn credit for this course, participants must (1) complete the 12.0-hour home study material and pass the accompanying home study assessment with a score of 70% or greater, and (2) attend one, full 8.0-hour live session and pass the accompanying final assessment with a score of 70% or greater. Two chances to pass each assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.

Upon successful completion of the course, participants will be awarded a certificate of completion which may be used to apply for Pharmacist Collaborative Practice Certification with the Florida Board of Pharmacy.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.

The Zoom link and information for the virtual live session will be provided within the Canvas course.


Acknowledgements and Disclosures

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB (speaker) has disclosed that he receives an unrestricted Investigator-initiated Research Grant from BMS/Pfizer. All of the relevant financial relationships listed for Dr. Dietrich have been mitigated. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.

Advisory Board

Katie Vogel Anderson
Department: Pharmacotherapy & Translational Research

Katie Vogel Anderson Pharm.D., BCACP, FCCP

Teresa E Roane
Department: Pharmacotherapy & Translational Research

Teresa E Roane PharmD, MBA, BCACP

Eric Rosenberg
Department: Department of Internal Medicine

Eric Rosenberg MD, MSPH, FACP

Rachel Shaddock
Department: Pharmacotherapy & Translational Research

Rachel Shaddock

Siegfried O Schmidt
Department: MD-CHFM SPRINGHILL

Siegfried O Schmidt MD, PhD

John Gums
Department: Pharmacotherapy & Translational Research

John Gums Pharm.D., FCCP

Faculty

Eric A Dietrich
Department: Pharmacotherapy & Translational Research

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Tracy E Leonard
Department: Pharmacotherapy & Translational Research

Tracy E Leonard R.Ph., BCPP, BCACP, CDCES, CPh

Carol A Motycka
Department: Jacksonville Campus

Carol A Motycka Pharm.D., BCACP

Lihui Yuan
Department: Pharmacodynamics

Lihui Yuan Pharm.D., Ph.D., R.Ph.

Eric F Egelund
Department: Jacksonville Campus

Eric F Egelund Ph.D., Pharm.D.

Lindsey Childs-Kean
Department: Pharmacotherapy & Translational Research

Lindsey Childs-Kean Pharm.D., M.P.H., BCPS


What do our students have to say about Collaborative Practice?

I thoroughly enjoyed UF’s CPA Agreement class. I feel it has enhanced my knowledge of various chronic conditions that require medication management along with providing a great walkthrough on how to compose and market a CPA. I would certainly recommend it to any person who works in or wants to integrate themselves into a health care team setting“.

Damon Burkhart, PharmD, CPh, CDCES

CPA Infographic

Collaborative Practice Agreements in Action

Curious how a collaborative practice agreement can impact your practice? Check out the interviews below to see how our pharmacists are making a difference!

Interview with Neal Holland, D.O.

Interview with Ryan Nall, M.D.


Q: How does the Collaborative Practice Agreement certificate program compare to the Ambulatory Care certificate program?

  • The Collaborative Practice Agreement training program meets the requirements outlined by the State of Florida for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician. Health conditions covered in this program include those pharmacists are allowed to manage according to the Florida law plus incorporates elements of the Florida rules and regulations for establishing a collaborative practice agreement, business principles necessary to assist with development of a practice site, and guidance on drafting a collaborative practice agreement protocol. In addition, this program contains a self-study portion as well as a live, interactive portion to meet Florida law requirements.
  • The Ambulatory Care certificate training program is designed as a resource to help prepare the pharmacist provide patient-centered care in a wide variety of ambulatory care settings with the goal of improving patient outcomes. It is also designed to serve as a starting point to help the pharmacist prepare for the Ambulatory Care board certification exam. The health conditions covered may include those covered in the Collaborative Practice Agreement training program; however, additional disease states are included that are not covered. This program is self-paced and fully online.
  • Some of the content may overlap between the programs; however, they are structured differently and the content overall is different.

Please see the Collaborative Practice Agreement FAQ for more information.


Collaborative Practice Agreement Resources

Centers for Disease Control and Prevention

Increasing the Use of Collaborative Practice Agreements Between Prescribers and Pharmacists

Collaborative Practice Agreements and Pharmacists’ Patient Care Services

Advancing Team-Based Care Through Collaborative Practice Agreements

Florida Board of Pharmacy


Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.